Allan I. Levey, MD, PhD

Professor and Chair
Emory University School of Medicine
Atlanta, Georgia

I am a cognitive neurologist and neuroscientist with many years of experience with Alzheimer’s disease and related disorders, and I also serve as Chair of the Department of Neurology and Director of the Goizueta Alzheimer’s Disease Research Center (GADRC). I lead several NIH initiatives including a program in the Accelerating Medicine Partnership for AD (AMP-AD; U01 AG04616; U01 AG061357) and the Open Drug Discovery Center for AD (aka, TREAT-AD; U54AG065187) . A central goal of my research is identification of novel therapeutic targets and biomarkers, leveraging our GADRC and platforms for mass spectrometry-based proteomics profiling of several thousand postmortem brains and biofluids (CSF and plasma) for late onset AD discovery and validation of a new generation of biomarkers including those that mark the preclinical evolution of pathophysiologies (e.g., synaptic, neuro-inflammatory, cytoskeletal, etc.). I have worked closely with the PIs to review the plans and leverage our efforts, including our extensive data available to facilitate the proposed research.